Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of aTyr Pharma's Stalaris?
Stalaris is a fusion protein commercialized by aTyr Pharma, with a leading Phase III program in Pulmonary Sarcoidosis. According to...